Abstract
Background
Marfan syndrome (MFS) is a connective tissue disease involving multiple organs and systems such as cardiovascular, skeletal, and ocular systems and is also an autosomal dominant inheritance disorder.
Method
A 30-year-old woman was rushed into the hospital owing to sudden persistent pain in the abdomen and died suddenly 2 days later. To find the real cause of death, a forensic autopsy was conducted owing to suspected medical malpractice, and the diagnosis of MFS was made in accordance with the 2010 revised Ghent nosology. By sequencing the gene of Marfan, aneurysm, and related disorders, a novel splicing mutation in the fibrillin-1 gene (FBN1) was detected. For the clinical characteristic findings (wrist and thumb sign) of the daughter, we recommend genetic analysis for the family. To better understand the role of the variant in the disease, we also investigated functional validation of this mutation.
Results
According to the autopsy findings, the cause of death was acute cardiac tamponade caused by aortic rupture. DNA sequencing revealed a novel splicing mutation, c.5672-2delA, which was also detected in her daughter (II2). The functional validation of this mutation showed the base deletion at the same site in the PCR products using cDNA as a template. It is suggested that this mutation may cause abnormal spliceosome during transcription and may encode abnormal protein.
Conclusion
A novel pathogenic splicing mutation (c.5672-2delA) was confirmed. Present work enriches the profile mutations in FBN1 associated with MFS and stresses the importance of postmortem genetic analysis in such cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Araújo MR, Marques C, Freitas S, Santa-Bárbara R, Alves J, Xavier C (2016) Marfan syndrome: new diagnostic criteria, same anesthesia care? Case report and review. Braz J Anesthesiol 66:408–413
Möberg K, De Nobele S, Devos D et al (2012) The Ghent Marfan trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers. Int J Cardiol 157(3):354–358
Dong J, Bu J, Du W et al (2012) A new novel mutation in FBN1causes autosomal dominant Marfan syndrome in a Chinese family. Mol Vis 18:81–86
Howarth R, Yearwood C, Harvey JF (2007) Application of dHPLC for mutation detection of the fibrillin-1 gene for the diagnosis of Marfan syndrome in a National Health Service Laboratory. Genet Test 11:146–152
Landis BJ, Veldtman GR, Ware SM (2017) Genotype-phenotype correlations in Marfan syndrome. Heart 103:1750–1752
Verstraeten A, Alaerts M, Van Laer L et al (2016) Marfan syndrome and related disorders: 25 years of gene discovery. Hum Mutat 37:524–531
Biery NJ, Eldadah ZA, Moore CS, Stetten G, Spencer F, Dietz HC (1999) Revised genomic organization of FBN1 and significance for regulated gene expression. Genomics 56:70–77
Boileau C, Jondeau G, Mizuguchi T, Matsumoto N (2005) Molecular genetics of Marfan syndrome. Curr Opin Cardiol 20:194–200
Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339
Franken R, den Hartog AW, Radonic T, Micha D, Maugeri A, van Dijk FS, Meijers-Heijboer HE, Timmermans J, Scholte AJ, van den Berg MP, Groenink M, Mulder BJM, Zwinderman AH, de Waard V, Pals G (2015) Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circ Cardiovasc Genet 8:383–388
Dietz HC (2015) Potential phenotype-genotype correlation in Marfan syndrome: when less is more? Circ Cardiovasc Genet 8:256–260
Hilhorst-Hofstee Y, Hamel BC, Verheij JB et al (2011) The clinical spectrum of complete FBN1 allele deletions. Eur J Hum Genet 19:247–252
Liu W, Schrijver I, Brenn T, Furthmayr H, Francke U (2001) Multi-exon deletions of the FBN1 gene in Marfan syndrome. BMC Med Genet 2:11
Dean JC (2007) Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 15:724–733
Hutchinson S, Wordsworth BP, Handford PA (2001) Marfan syndrome caused by a mutation in FBN1 that gives rise to cryptic splicing and a 33 nucleotide insertion in the coding sequence. Hum Genet 109:416–420
Karttunen L, Ukkonen T, Kainulainen K et al (1998) Two novel fibrillin-1 mutations resulting in premature termination codons but in different mutant transcript levels and clinical phenotypes. Hum Mutat Suppl 1:S34–S37
Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 11:7155–7174
Kim HW, Stansfield BK (2017) Genetic and epigenetic regulation of aortic aneurysms. Biomed Res Int 2017:7268521–7268512. https://doi.org/10.1155/2017/7268521
Pannu H, Tran-Fadulu V, Milewicz DM (2005) Genetic basis of thoracic aortic aneurysms and aortic dissections. Am J Med Genet C: Semin Med Genet 139C:10–16
de Boer HH, Dedouit F, Chappex N, van der Wal AC, Michaud K (2017) Sudden aortic death—proposal for a comprehensive diagnostic approach in forensic and in clinical pathology practice. Int J Legal Med 131:1565–1572. https://doi.org/10.1007/s00414-017-1560-3
Klintschar M, Bilkenroth U, Arslan-Kirchner M, Schmidtke J, Stiller D (2009) Marfan syndrome: clinical consequences resulting from a medicolegal autopsy of a case of sudden death due to aortic rupture. Int J Legal Med 123(1):55–58
Hugar BS, Praveen S, Kainoor SK, Shetty AR (2014) Sudden death in Marfan syndrome. J Forensic Sci 59:1126–1128. https://doi.org/10.1111/1556-4029.12415
Wang Y, Chen S, Wang R, Huang S, Yang M, Liu L, Liu Q (2016) Postmortem diagnosis of Marfan syndrome in a case of sudden death due to aortic rupture: detection of a novel FBN1 frameshift mutation. Forensic Sci Int 261:e1–e4
Baudhuin LM, Kotzer KE, Lagerstedt SA (2015) Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med 17:177–187
Funding
This work was supported by the National Key Research and Development Program of China (2018YFC0807203).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Written informed consent for publishing this scientific report was obtained from the direct relative of the decedent in this case.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhao, S., Duan, Y., Huang, F. et al. A novel splicing mutation in Marfan syndrome. Int J Legal Med 134, 2161–2166 (2020). https://doi.org/10.1007/s00414-020-02371-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-020-02371-4